Journals Library


Project Published

View Report

  • Latest project information

HTA - 09/141/01

Rituximab for the first-line treatment of stage III-IV follicular lymphoma (Review of TA 110): systematic review and economic evaluation

Project title: Rituximab for the first-line treatment of stage III-IV follicular lymphoma (Review of TA 110): systematic review and economic evaluation

Call to action: 14/133 Batch 10

Chief investigator: Ms Diana Papaioannou

Lead Author: Ms Diana Papaioannou

Contractor: The University of Sheffield

Co-investigators: Professor Matt Stevenson.

Started: December 2010 | Status: Published October 2012

Study finds that the combination of rituximab with chemotherapy is likely to be clinically effective in the first-line treatment of stage III-IV follicular lymphoma. The cost per quality-adjusted life-year gained is estimated to be £25,000 for all three chemotherapy regimens compared and is considerably lower if first-line rituximab maintenance is not assumed.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.